How can we optimally treat patients with hairy cell leukemia (HCL)?
HCL is a rare disease and the therapeutic management could be a suject of discussion. We present here the different options in newly and relapsed/refractory HCL patients.
We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website. You can decide for yourself which categories you want to deny or allow. Please note that based on your settings not all functionalities of the site are available.
Further information can be found in our privacy policy.